Accession Number: | 0001213900-22-019771 |
Date: | 2022-04-13 |
Issuer: | ENZO BIOCHEM INC (ENZ) |
Original Submission Date: |
ERFANIAN HAMID
C/O ENZO BIOCHEM, INC.
527 MADISON AVENUE
NEW YORK, NY 10022
Title of Security | Transaction Date | 2a. Deemed Execution Date | Transaction Code | Shares | Acquired or Disposed | Price per share | 5. Amount of Securities Beneficially Owned Following Reported Transaction | 6. Ownership Form Direct or Indirect | Nature of Indirect Ownership |
---|---|---|---|---|---|---|---|---|---|
COMMON STOCK, $0.01 PAR VALUE | 2022-04-13 | A | 10,000 | a | $2.90 | 270,000 | direct |
Title of Derivative Security | Conversion or Exercise Price of Derivative Security | Transaction Date | Deemed Execution Date | Transaction Code | Number of Derivative Securities Acquired (A) or Disposed of (D) | Date Exercisable | Expiration Date | Title and Amount of Securities Underlying Derivative Security | Price of Derivative Security | Number of derivative Securities Beneficially Owned Following Reported Transaction(s) | Ownership Form: Direct (D) or Indirect (I) | Nature of Indirect Beneficial Ownership |
---|---|---|---|---|---|---|---|---|---|---|---|---|
STOCK OPTION (TO ACQUIRE COMMON STOCK) | 3.39 | 2021-11-08 | deemed execution date | A | 700,000 (a) | 2022-11-08 | 2026-11-08 | common stock 700,000 | $3.39 | 700,000 | direct |
ID | footnote |
---|---|
f1 | the reporting person was granted 700,000 stock options. the stock options have a five-year term and will vest, subject to the individual's continued employment with enzo biochem, inc., in three equal annual installments, beginning on november 8, 2022. |